• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Fierce panel London
Biotech

Fierce’s London event told it could be ‘Europe’s year to shine’

Panelists at Fierce Biotech's London Life Sciences Week event discussed whether Europe can pull its weight in biopharma investment next year.
Ben Adams Nov 17, 2026 10:00am
Photo of an ax atop a pile of three logs

Kyntra drops mid-stage ADC, adding to years of stumbles

Nov 17, 2026 10:40am
digital dollar concept financial technology investment funding

Isomorphic Labs raises $5B series C months after $2.1B round

Nov 17, 2026 9:20am
colorful brain art model
Favicon Fierce Pharma

AriBio’s oral Alzheimer’s drug meets monotherapy goal in ph. 3

Nov 17, 2026 7:43am
An artists depiction of different types of blood cells from bone marrow

Marrow extracts $120M series B for blood disease drug

Nov 17, 2026 7:00am
On target clinical trial success bullseye score

Sellas marks 9-month survival in ph. 3 leukemia vaccine study

Nov 17, 2026 7:00am
More News

Lilly signs $5.9B deal with Stipple to unlock oncology targets

Nov 17, 2026 5:30am

CG’s newest late-stage bladder cancer results broaden potential

Nov 16, 2026 2:05pm

Helus scores ph. 3 depression win for modified psychedelic

Nov 16, 2026 10:40am

Biogen inks $411M pact for TrimTech’s protein degrader skills

Nov 16, 2026 10:00am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings